2008
DOI: 10.1016/j.bbrc.2008.06.046
|View full text |Cite
|
Sign up to set email alerts
|

6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
82
1
2

Year Published

2009
2009
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 140 publications
(92 citation statements)
references
References 27 publications
3
82
1
2
Order By: Relevance
“…This metabolic change occurs via peroxisome proliferator-activated receptors (PPAR), which are involved in adipocyte differentiation [20] [21] [22] [23]. One of the components of GP, 6-shogaol, has been proven to activate PPAR [24]. Hence, the unchanged liver weight of mice in the GP groups compared with those of mice in the HFD group observed in this present study might be due to increased PPAR-stimulated hepatic peroxisome induction.…”
Section: Discussionmentioning
confidence: 78%
“…This metabolic change occurs via peroxisome proliferator-activated receptors (PPAR), which are involved in adipocyte differentiation [20] [21] [22] [23]. One of the components of GP, 6-shogaol, has been proven to activate PPAR [24]. Hence, the unchanged liver weight of mice in the GP groups compared with those of mice in the HFD group observed in this present study might be due to increased PPAR-stimulated hepatic peroxisome induction.…”
Section: Discussionmentioning
confidence: 78%
“…It is traditionally used for the treatment of rheumatism, nervous diseases, gingivitis, toothache, asthma, constipation, diabetes, and arthritis [21]. It has phytoconstituents that have anti-inflammatory, anti-oxidant and anticancer effects [22,23]. P. spicigera, from the family Leguminosae, is not an extensively studied plant as not much literature is available.…”
Section: Discussionmentioning
confidence: 99%
“…However, this is bound to be an oversimplification, since pharmacokinetic studies are needed to determine concentrations in different organs and cell compartments, whilst the optimal therapeutic effects may be contributed by multiple activities. Other mechanisms of Zingiber officinale and its components include upregulation of adiponectin by 6-shogaol and 6-gingerol and PPAR-agonistic activity of 6-shogaol (but not 6-gingerol) [113], activation of hepatic cholesterol-7 -hydroxylase to stimulate the conversion of hepatic cholesterol to bile acids [114,115], increase in the faecal excretion of cholesterol and possible block of absorption of cholesterol in the gut [116], and inhibition of cellular cholesterol biosynthesis described in an apolipoprotein E-deficient mouse [117]. Other possible effects are related to its COX2 actions in diabetic chronic inflammation and effects on carbohydrate through inhibition of hepatic phosphorylase (to prevent the glycogenolysis in hepatic cell) and increase of enzyme activities contributing to progression of glycogenesis and inhibition of the activity of hepatic glucose-6-phosphatase (thereby decreasing glucose phosphorylation and contributing to lowering blood glucose) [40].…”
Section: The Multiple Targets Of Ginger Actionmentioning
confidence: 99%